
Internis hires Sandoz’ Paul Tredwell as COO
pharmafile | August 1, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | Internis, Tredwell
Developer and supplier of bone disorder treatments Internis Pharmaceuticals has appointed Paul Tredwell as chief operating officer.
Tredwell will report to Alan Walker, joint chief executive, and joins Internis from Sandoz, where he was head of Biopharmaceuticals. In 2010 Tredwell set up a new division in the UK and was directly responsible for managing sales, marketing and medical.
Tredwell began his career in the pharma industry with Galen 16 years ago. Promoted to area sales manager, he then moved to Shire where he held lead the UK specialist sales teams as well as the commercial and NHS teams.
Walker said: “We are delighted to have Paul Tredwell join our team. Paul is a recognised global leader in his field. His skills, knowledge and extensive experience in the industry, as well as his ability to deliver results, make him the ideal candidate to lead Internis into the next exciting phase of its development.”






